A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer
Clinical trial NCT00887536 · COMPLETED
Trial details
- NCT number
- NCT00887536
- Sponsor
- NSABP Foundation Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-05-01
- Primary completion
- 2018-02-01
- Enrollment
- 1613
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.